Bayer stock at EUR 54.96, down 2.24% before Xetra open
Published on 11/06/2026 at 08:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBayer's three operating businesses
- Bayer operates across Crop Science, Pharmaceuticals and Consumer Health.
- The company focuses on solutions for essential health care and food needs.
- Investor-relations materials include Q3 2026 results, quarterly communications and half-year financial reports.
Bayer stock traded at EUR 54.96 on Lang & Schwarz at 08:42:53 CET on Friday, November 6, 2026, 2.24 percent below the Xetra close of Thursday, November 5, 2026 at EUR 56.22.
According to Bayer Investor Relations, the group develops solutions for essential health care and food needs. Its main businesses are Crop Science, Pharmaceuticals and Consumer Health, giving the company exposure to agricultural inputs, prescription medicines and consumer health products.
What investors should watch next
Bayer's investor-relations agenda includes Q3 2026 results, quarterly communications for the first and third quarters, and half-year financial reports. These publications remain central for investors assessing operating momentum across the three divisions and the outlook for 2026.
Investors can follow the real-time quote of Bayer stock.
German equities will provide the broader market backdrop as trading begins.
More news and analyses on Bayer stock are available in the topic overview.
